Recently, pro-nociceptin and leukocyte-associated immunoglobulin-like receptor 2 were identified as biomarkers for assessment of immune infiltration in cholangiocarcinoma using a combination of batch sequencing and single-cell sequencing (Chen et al., 2021). This evidence concerns the gene PNOC and cholangiocarcinoma.